SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001279569-16-004154
Filing Date
2016-08-10
Accepted
2016-08-10 16:29:13
Documents
4
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v446251_10q.htm 10-Q 864262
2 EXHIBIT 31.1 v446251_ex31-1.htm EX-31.1 7238
3 EXHIBIT 31.2 v446251_ex31-2.htm EX-31.2 7373
4 EXHIBIT 32.1 v446251_ex32-1.htm EX-32.1 5978
  Complete submission text file 0001279569-16-004154.txt   885808
Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9
Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449
Cynapsus Therapeutics Inc. (Filer) CIK: 0001532079 (see all company filings)

IRS No.: 981226819 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37426 | Film No.: 161821853
SIC: 2834 Pharmaceutical Preparations